ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Zydus Lifesciences Ltd Complete list of announcements declared & dividend announcements by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences Ltd ZYDUSLIFE listed on NSE and deals in

Announcements and dividends declared by Zydus Lifesciences Ltd ZYDUSLIFE

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding 'Revised ESG Score'.
Announcement as on 05 March 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 05, 2025, titled "Zydus Lifesciences launches ANVIMO, a breakthrough for transplant patients Made-in-India for India, ANVIMO brings access and affordability".
Announcement as on 05 March 2025

Zydus Lifesciences launches breakthrough drug for transplant patients
Zydus Lifesciences introduces ANVIMO (Letermovir) for CMV prevention in transplant patients, offering a safer, better-tolerated alternative to traditional treatments. The new medication, made available at significantly reduced costs, aims to improve transp
Announcement as on 05 March 2025

Zydus Lifesciences inks licensing pact with Zhuhai for cancer drug
Zydus Lifesciences' subsidiary partners with Zhuhai Beihai Biotech to market Beizray, a cancer drug, in the US. Zhuhai will handle manufacturing while Zydus will commercialize the product, targeting breast cancer and other types. The partnership includes m
Announcement as on 14 February 2025

Zydus Lifesciences in pact with Synthon for specialty oncology product in US
Zydus Lifesciences has signed an exclusive agreement with Synthon for the development and commercialisation of a novel oncology product, focusing on reducing pill burden and improving patient compliance. Synthon will handle development and manufacturing, w
Announcement as on 12 February 2025

Announcements by Zydus Lifesciences Ltd first page | Next page | Prev page |

ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals

Moving Averages for Zydus Lifesciences Ltd

  • 5Day Average: 1074.68
  • 12Day Average: 1087.43
  • 20Day Average: 1082.48
  • 50Day Average: 999.48
  • 100Day Average: 948.6
  • 150Day Average: 938.92
  • 200Day Average: 954.52

ZYDUSLIFE Indicators & signals

Indicator MACD (12,26,9)

1078.47, 1056.27, 30.48
Indicator MACD is in positive zone

Indicator ADX (14)

17.97, 25.33, 17.61
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Fri Jun 2026 1070.80 1065.00 to 1083.00 -0.34% 0.79 times
18 Thu Jun 2026 1074.40 1060.60 to 1082.50 1.22% 1.17 times
17 Wed Jun 2026 1061.40 1053.80 to 1077.80 -1.6% 2.22 times
16 Tue Jun 2026 1078.70 1072.40 to 1091.60 -0.86% 0.93 times
15 Mon Jun 2026 1088.10 1086.00 to 1112.10 -1.5% 1.01 times
12 Fri Jun 2026 1104.70 1101.70 to 1118.00 -0.11% 0.78 times
11 Thu Jun 2026 1105.90 1091.20 to 1110.40 0.69% 0.65 times
10 Wed Jun 2026 1098.30 1095.10 to 1119.80 -0.66% 0.53 times
09 Tue Jun 2026 1105.60 1085.50 to 1111.00 1.66% 1.16 times
08 Mon Jun 2026 1087.60 1076.20 to 1100.00 -0.13% 0.74 times
05 Fri Jun 2026 1089.00 1082.20 to 1097.00 0.41% 0.82 times
04 Thu Jun 2026 1084.60 1063.10 to 1098.00 0.74% 0.9 times

Videos related to: ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

 

Back to top